DiaSorin S.p.A. (DIA)
MTA
Closed
Aug 25, 2026
Day's Range
74.9252 wk Range
52.34Overview - DIA - DiaSorin S.p.A.
Key Statistics
Valuation
Enterprise Value
4.55B
P/E (Trailing)
‪27.75‬
P/E (Forward)
‪17.60‬
PEG Ratio
‪-7.52‬
Price / Sales (TTM)
‪3.16‬
Price / Book
‪2.62‬
EV / EBITDA
‪13.27‬
Profitability
Profit Margin
‪11.93%‬
Operating Margin
‪22.21%‬
Return on Assets
‪5.54%‬
Return on Equity
‪9.16%‬
Ownership
Shares Outstanding
49.49M
Float
14.95M
Held by Insiders
‪57.55%‬
Held by Institutions
‪14.13%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪70.09‬
200-Day Avg
‪67.16‬
Dividends
Payout Ratio
‪47.79%‬
Frequency
Annual
Analyst Consensus
14 analysts
Average price target
‪€ 71.66‬Market Cap - DIA - DiaSorin S.p.A.
Peers - DIA - DiaSorin S.p.A.
Peer Comparison
Compared with companies in Diagnostics & Research listed on MTA.
Profile Summary - DIA - DiaSorin S.p.A.
About
DiaSorin S.p.A. is a global leader in the laboratory diagnostics market, specializing in immunodiagnostics and molecular diagnostics segments. Founded in 2000 and headquartered in Saluggia, Italy, the company develops, manufactures, and markets advanced in vitro diagnostic reagent kits and instruments for detecting…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
